NCT04203147Completed
Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM
HOME DM-BAT: Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
The objective of this protocol is to evaluate the efficacy and cost-effectiveness of 8 sessions of in-home, telephone-delivered, culturally-modified, manualized diabetes-modified, behavioral activation treatment (Home DM-BAT) delivered by trained diabetes nurse educators among low income, ethnic minority seniors with poorly controlled T2DM. The aims of this randomized controlled efficacy trial are: Aim: To test the efficacy of Home DM-BAT on glycemic control (hemoglobin A1c). Hypothesis: Low income, minority seniors with poorly controlled T2DM randomized to Home DM-BAT will have significantly greater improvements in glycemic control (hemoglobin A1c) at 12 months of follow-up compared to the control group (in-home, telephone-delivered supportive therapy - ST).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 200 (actual)
- First submitted
- 26 Nov 2019
- Start date
- 3 Jan 2020
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- State University of New York at Buffalo
- Diseases
- Type 2 diabetes
- NCT number
- NCT04203147
What you commit to
- Study type: Interventional
- Participants enrolled: 200
- From 3 Jan 2020 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Alcohol or drug abuse/dependency;
Other illness
- Mental confusion at screening assessment suggesting significant dementia;
- Participation in other diabetes research;
- Active psychosis or acute mental disorder; and
Other
- Life expectancy \<12 months at screening assessment.
Who the study is looking for
- Age \>=65 years of age;
- Self-identified as Black/African American or Hispanic;
- Clinical diagnosis of T2DM verified by an HbA1c \>=8% at the screening assessment;
- Able to communicate in English or Spanish; and
- Resident of independent, subsidized, assisted senior housing facility or community dwelling elderly adults in the greater Milwaukee area and surrounding counties that have high African American/Hispanic populations.
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| State University of New York at Buffalo Coordinator of this site? Confirm its status | Buffalo | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.